AG-13958 |
Catalog No.GC35263 |
강력한 VEGFR 티로신 키나제 억제제인 AG-13958(AG-013958)은 연령 관련 황반변성(AMD)과 관련된 맥락막 신생혈관의 치료에 사용됩니다.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 319460-94-1
Sample solution is provided at 25 µL, 10mM.
AG-13958 (AG-013958), a potent VEGFR tyrosine kinase inhibitor, is used for treatment of choroidal neovascularization associated with age-related macular degeneration (AMD)[1]. VEGFR
[1]. M.B. Kosa, et al. Ocular and Systemic Pharmacokinetics of AG-013958 With Sub-Tenon Administration To Cynomologus Monkeys. Investigative Ophthalmology & Visual Science May 2005, Vol.46, 5379.
Average Rating: 5
(Based on Reviews and 19 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *